Cleveland BioLabs Announces Expanded U.S. Patent Protection for Entolimod
November 30, 2015 at 07:30 AM EST
Cleveland BioLabs, Inc. (NASDAQ: CBLI) today announced the allowance of two new patent applications by the U.S. Patent Office with ...